Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1978 Oct;38(4):481–495. doi: 10.1038/bjc.1978.235

Surface antigens in acute myeloblastic leukaemia: a study using heterologous antisera.

L Tupchong, I C MacLennan
PMCID: PMC2009758  PMID: 281967

Abstract

This study analyses the activity of 95 antisera raised in rabbits against human leukaemic myeloblasts. A number of different means were used to immunize both normal rabbits and rabbits which had been treated to render them tolerant of normal human splenic leucocytes. Different immunization schedules included the use of different doses of untreated myeloblasts, as well as myeloblasts treated with neuraminidase, antibody against human spleen cells or glutaraldehyde. Analysis of the sera was carried out using two sensitive techniques for detecting cell surface antigens: a radioactive anti-immunoglobulin binding assay using 125I-horse-F(ab')2-anti-rabbit-Fab and a K-cell-mediated cytotoxicity test using rat spleen cells as effectors. (i) The unabsorbed sera showed similar mean titres against leukaemic myeloblasts and normal splenocytes. (ii) Extensive absorption with pooled cadaveric spleen were required to remove antibody against polymorphic antigens. (iii) 17/95 antisera had activity against at least some leukaemic myeloblasts after extensive absorption with cadaveric spleen. (iv) Some of the 17 absorbed sera with selective activity for myeloblasts also reacted against PHA-induced lymphoblasts. (v) Although the 17 absorbed sera showed little or no activity against marrow in the above assays normal human marrow totally absorbed all residual activity in these sera against leukaemic myeloblasts. We conclude that although these sera contain activity against antigens common to leukaemic myeloblasts and a minority population of normal marrow cells, they have no detectable activity against leukaemic-specific antigens.

Full text

PDF
481

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arbeit R. D., Sachs D. H., Amos D. B., Dickler H. B. Human lymphocyte alloantigen(s) similar to murine Ir region-associated (Ia) antigens. J Immunol. 1975 Oct;115(4):1173–1175. [PubMed] [Google Scholar]
  2. Avrameas S., Ternynck T. The cross-linking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents. Immunochemistry. 1969 Jan;6(1):53–66. doi: 10.1016/0019-2791(69)90178-5. [DOI] [PubMed] [Google Scholar]
  3. Baker M. A., Taub R. N., Brown S. M., Ramachandar K. Delayed cutaneous hypersensitivity in leukaemic patients to autologous blast cells. Br J Haematol. 1974 Aug;27(4):627–634. doi: 10.1111/j.1365-2141.1974.tb06629.x. [DOI] [PubMed] [Google Scholar]
  4. Bias W. B., Santos G. W., Burke P. J., Mullins G. M., Humphrey R. L. Cytotoxic antibody in normal human serums reactive with tumor cells from acute lymphocytic leukemia. Science. 1972 Oct 20;178(4058):304–306. doi: 10.1126/science.178.4058.304. [DOI] [PubMed] [Google Scholar]
  5. Billing R., Rafizadeh B., Drew I., Hartman G., Gale R., Terasaki P. Human B-lymphocyte antigens expressed by lymphocytic and myelocytic leukemia cells. I. Detection by rabbit antisera. J Exp Med. 1976 Jul 1;144(1):167–178. doi: 10.1084/jem.144.1.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Billing R., Ting A., Terasaki P. I. Human B-lymphocyte antigens expressed by lymphocytic and myelocytic leukemia cells. II. Detection by human anti-B-cell alloantisera. J Natl Cancer Inst. 1977 Feb;58(2):199–203. doi: 10.1093/jnci/58.2.199. [DOI] [PubMed] [Google Scholar]
  7. Cresswell P., Geler S. S. Antisera to human B-lymphocyte membrane glycoproteins block stimulation in mixed lymphocyte culture. Nature. 1975 Sep 11;257(5522):147–149. doi: 10.1038/257147a0. [DOI] [PubMed] [Google Scholar]
  8. Cullen P. R., Mason D. Y. Leukaemia-associated antigens in man. Detection by antibodies in maternal sera. Clin Exp Immunol. 1974 Aug;17(4):571–586. [PMC free article] [PubMed] [Google Scholar]
  9. Durantez A., Zighelboim J., Gale R. P. Leukemia-associated antigens detected by heterologous antisera. J Natl Cancer Inst. 1976 Jun;56(6):1217–1219. doi: 10.1093/jnci/56.6.1217. [DOI] [PubMed] [Google Scholar]
  10. Einstein A. B., Jr, Mann D. L., Gordon H. G., Trapani R. J., Fahey J. L. Heterologous antisera against specific HL-A antigens. Transplantation. 1971 Oct;12(4):299–304. doi: 10.1097/00007890-197110000-00011. [DOI] [PubMed] [Google Scholar]
  11. Freeman C. B., Harris R., Geary C. G., Leyland M. J., MaCiver J. E., Delamore I. W. Active immunotherapy used alone for maintenance of patients with acute myeloid leukaemia. Br Med J. 1973 Dec 8;4(5892):571–573. doi: 10.1136/bmj.4.5892.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fridman W. H., Kourilsky F. M. Stimulation of lymphocytes by autologous leukaemic cells in acute leukaemia. Nature. 1969 Oct 18;224(5216):277–279. doi: 10.1038/224277a0. [DOI] [PubMed] [Google Scholar]
  13. Fu S. M., Winchester R. J., Kunkel H. G. The occurrence of the HL-B alloantigens on the cells of unclassified acute lymphoblastic leukemias. J Exp Med. 1975 Nov 1;142(5):1334–1338. doi: 10.1084/jem.142.5.1334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. GARB S., STEIN A. A., SIMS G. The production of anti-human leukemic serum in rabbits. J Immunol. 1962 Feb;88:142–152. [PubMed] [Google Scholar]
  15. Gale D. G., MacLennan I. C. Cytotoxic antibody in acute myeloblastic leukaemia during immunotherapy: lack of tumour specificity. Br J Cancer. 1977 Mar;35(3):280–287. doi: 10.1038/bjc.1977.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Greaves M. F. Clinical applications of cell surface markers. Prog Hematol. 1975;9:255–303. [PubMed] [Google Scholar]
  17. Humphrey J. H. Haemolytic efficiency of rabbit IgG anti-Forssman antibody and its augmentation by anti-rabbit IgG. Nature. 1967 Dec 30;216(5122):1295–1296. doi: 10.1038/2161295a0. [DOI] [PubMed] [Google Scholar]
  18. Hyde R. M., Garb S., Bennett A. J. Demonstration by immunoelectrophoresis of antigen in human myelogenous leukemia. J Natl Cancer Inst. 1967 Jun;38(6):909–920. [PubMed] [Google Scholar]
  19. Jensenius J. C., Williams A. F. The binding of anti-immunoglobulin antibodies to rat thymocytes and thoracic duct lymphocytes. Eur J Immunol. 1974 Feb;4(2):91–97. doi: 10.1002/eji.1830040207. [DOI] [PubMed] [Google Scholar]
  20. Klouda T. P., Lawler S. D., Powles R. L., Oliver R. T., Grant C. K. HL-A antibody response in patients with acute myelogenous leukaemia treated by immunotherapy. Transplantation. 1975 Mar;19(3):245–249. doi: 10.1097/00007890-197503000-00008. [DOI] [PubMed] [Google Scholar]
  21. Kuntz M. M., Innes J. B., Weksler M. E. Lymphocyte transformation induced by autologous cells. IV. Human T-lymphocyte proliferation induced by autologous or allogeneic non-T lymphocytes. J Exp Med. 1976 May 1;143(5):1042–1054. doi: 10.1084/jem.143.5.1042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Linscott W. D. Effect of cell surface antigen density on immunological enhancement. Nature. 1970 Nov 28;228(5274):824–827. doi: 10.1038/228824a0. [DOI] [PubMed] [Google Scholar]
  23. Lohrmann H. P., Novikovs L., Graw R. G., Jr Stimulatory capacity of human T and B lymphocytes in the mixed leukocyte culture. Nature. 1974 Jul 12;250(462):144–146. doi: 10.1038/250144a0. [DOI] [PubMed] [Google Scholar]
  24. MacLennan I. C. Antibody in the induction and inhibition of lymphocyte cytotoxicity. Transplant Rev. 1972;13:67–90. doi: 10.1111/j.1600-065x.1972.tb00060.x. [DOI] [PubMed] [Google Scholar]
  25. Mann D. L., Abelson L., Harris S., Amos D. B. Detection of antigens specific for B-lymphoid cultured cell lines with human alloantisera. J Exp Med. 1975 Jul 1;142(1):84–89. doi: 10.1084/jem.142.1.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Mann D. L., Leventhal B., Halterman R. Human antisera detecting leukemia-associated antigens on autochthonous tumor cells. J Natl Cancer Inst. 1975 Feb;54(2):345–347. [PubMed] [Google Scholar]
  27. Mann D. L., Rogentine G. N., Halterman R., Leventhal B. Detection of an antigen associated with acute leukemia. Science. 1971 Dec 10;174(4014):1136–1137. doi: 10.1126/science.174.4014.1136. [DOI] [PubMed] [Google Scholar]
  28. Metzgar R. S., Mohanakumar T., Miller D. S. Antigens specific for human lymphocytic and myeloid leukemia cells: detection by nonhuman primate antiserums. Science. 1972 Dec 1;178(4064):986–988. doi: 10.1126/science.178.4064.986. [DOI] [PubMed] [Google Scholar]
  29. Mohanakumar T., Metzgar R. S., Miller D. S. Human leukemia cell antigens: serologic characterization with xenoantisera. J Natl Cancer Inst. 1974 May;52(5):1435–1444. doi: 10.1093/jnci/52.5.1435. [DOI] [PubMed] [Google Scholar]
  30. Opelz G., Gale R. P., McClelland J. D. Relationship between leukemia antigens and stimulation in mixed leukocyte culture. J Natl Cancer Inst. 1977 Jul;59(1):95–98. doi: 10.1093/jnci/59.1.95. [DOI] [PubMed] [Google Scholar]
  31. Opelz G., Kiuchi M., Takasugi M., Terasaki P. I. Autologous stimulation of human lymphocyte subpopulation. J Exp Med. 1975 Nov 1;142(5):1327–1333. doi: 10.1084/jem.142.5.1327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Powles R. L., Balchin L. A., Fairley G. H., Alexander P. Recognition of leukaemia cells as foreign before and after autoimmunization. Br Med J. 1971 Feb 27;1(5747):486–489. doi: 10.1136/bmj.1.5747.486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Powles R. L., Crowther D., Bateman C. J., Beard M. E., McElwain T. J., Russell J., Lister T. A., Whitehouse J. M., Wrigley P. F., Pike M. Immunotherapy for acute myelogenous leukaemia. Br J Cancer. 1973 Nov;28(5):365–376. doi: 10.1038/bjc.1973.162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Powles R. L., Russell J., Lister T. A., Oliver T., Whitehouse J. M., Malpas J., Chapuis B., Crowther D., Alexander P. Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient. Br J Cancer. 1977 Mar;35(3):265–272. doi: 10.1038/bjc.1977.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Reisfeld R. A., Kahan B. D. Extraction and purification of soluble histocompatibility antigens. Transplant Rev. 1971;6:81–112. doi: 10.1111/j.1600-065x.1971.tb00460.x. [DOI] [PubMed] [Google Scholar]
  37. Schlossman S. F., Chess L., Humphreys R. E., Strominger J. L. Distribution of Ia-like molecules on the surface of normal and leukemic human cells. Proc Natl Acad Sci U S A. 1976 Apr;73(4):1288–1292. doi: 10.1073/pnas.73.4.1288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Taylor G. M., Freeman C. B., Harris R. Response of remission lymphocytes to autochthonous leukaemic myeloblasts. Br J Cancer. 1976 May;33(5):501–511. doi: 10.1038/bjc.1976.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Zighelboim J., Bick A., Durantez A. Recognition by human and rabbit sera of common antigens to leukemia blast cells, peripheral blood B-lymphocytes, and monocytes. Cancer Res. 1977 Oct;37(10):3656–3662. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES